Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dexamfetamine 5mg tablets
0404000L0AAAJAJ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 18,644 |
|
Dexamfetamine 10mg tablets
0404000L0AABNBN
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 9,609 |
|
Amfexa 10mg tablets
0404000L0BGABBN
|
Amfexa | Dexamfetamine sulfate | Central Nervous System | 3,112 |
|
Dexamfetamine 20mg tablets
0404000L0AABPBP
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 2,867 |
|
Amfexa 5mg tablets
0404000L0BGAAAJ
|
Amfexa | Dexamfetamine sulfate | Central Nervous System | 2,370 |
|
Amfexa 20mg tablets
0404000L0BGACBP
|
Amfexa | Dexamfetamine sulfate | Central Nervous System | 1,022 |
|
Dexamfetamine 5mg/5ml oral solution sugar free
0404000L0AABMBM
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 238 |
|
Dexamfetamine 5mg/5ml oral liquid
0404000L0AAAMAM
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 12 |
|
Adderall XR 20mg capsules
0404000L0BFAEAF
|
Adderall | Dexamfetamine sulfate | Central Nervous System | 10 |
|
Amfetamine 15mg / Dexamfetamine 15mg modified-release caps
0404000L0AAAYAY
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | 4 |
|
Adderall 10mg tablets
0404000L0BFAAAV
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 10mg capsules
0404000L0BFAFBH
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 15mg capsules
0404000L0BFAHBE
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 25mg capsules
0404000L0BFAIBF
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 30mg capsules
0404000L0BFADAY
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 5mg capsules
0404000L0BFAGBD
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 10mg / Dexamfetamine 10mg modified-release caps
0404000L0AAAFAF
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 12.5mg / Dexamfetamine 12.5mg MR caps
0404000L0AABFBF
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 2.5mg / Dexamfetamine 2.5mg modified-release caps
0404000L0AABDBD
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 5mg / Dexamfetamine 5mg modified-release capsules
0404000L0AABHBH
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 5mg / Dexamfetamine 5mg tablets
0404000L0AAAVAV
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Amfetamine 7.5mg / Dexamfetamine 7.5mg modified-release caps
0404000L0AABEBE
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 100mg/5ml oral liquid
0404000L0AAAQAQ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 10mg modified-release capsules
0404000L0AABABA
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 10mg/5ml oral liquid
0404000L0AAANAN
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.